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and implementation results. RESULTS: Outpatient hemophilia treatment is 
covered by health insurance schemes in more than 80% of the selected cities, yet 
with reimbursement caps and patient co-pay requirements. While there is 
significant variation by city, the average co-pay requirement is more than 50% 
and annual reimbursement is usually capped below USD16k (100k CNY). 
However, some cities have pioneered innovative policies to provide better 
coverage for hemophilia patients: Guangzhou health insurance bureau has 
decreased hemophilia co-payments to less than 10% after their extensive review 
of the economics of hemophilia treatment. The local health insurance bureau in 
Qingdao has decided to joint-fund prophylaxis treatment for pediatric patients 
together with a FVIII manufacturer. CONCLUSIONS: Hemophilia treatment 
reimbursement in China is still at a low level overall despite a few pioneer cities 
which have identified unique approaches to reducing the economic burden of 
patients living with hemophilia. There is significant room to increase 
reimbursement ratio and cap to reduce patients’ economic burden, and 
meanwhile we expect tailored public-private partnerships to be a promising 
supplementing solution.  
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OBJECTIVES: In the Brazilian public health care system, the government 
establishes one value to reimburse the entire country for the use of different 
health care facilities. In the supplementary/private system, as a business-to-
business negotiation, each the hospital negotiates different reimbursement 
values with each payer for the use of distinct hospital facilities. There are eight 
different types of hospital facilities available in the supplementary system: 
standard, cardiovascular unit, surgery unit, psychiatric, day hospital, nursery, 
adult and pediatric ICU. The objective of this study is to find out and compare 
hospital facilities daily reimbursement values and establish a mean 
reimbursement value for each facility type in the private health care. METHODS: 
Data was obtained from BI.2iM database, a 5 million people sample of the 
Brazilian supplementary health care market. All values are in 2009 Brazilian reais 
(US$1.00 = R$ 2.00). Data are presented as mean±standard deviation RESULTS: 
65% of the patients are from medical cooperatives, HMOs 20%, self-management 
11%, others 4%. A total of 303,573 hospitalizations were reviewed with a total 
expenditure of R$ 82.9 million. The mean reimbursement for each facility type 
was: standard R$ 152.43±R$ 148.80; cardiovascular unit R$ 183.03±R$ 92.63; 
surgery unit R$ 202.06±R$ 87.74; psychiatric R$ 121.42±R$ 50.66; day hospital R$ 
79.60±R$ 23.50; nursery R$ 73.25±R$ 30.67; adult ICU R$ 625.82±R$ 305.71 and 
pediatric ICU R$ 762.91±R$ 330.58. CONCLUSIONS: There is not a single 
reimbursement list (health plans to the providers) or fixed values for hospital 
facilities daily reimbursement values. We found different mean values of 
hospital facilities daily reimbursement that vary according to the facility type. 
Even within the same facility type there is also reimbursement value variation.  
 
PHS126  
FACTORS INFLUENCING THE VARIATION IN HOSPITAL INPATIENT PRICES 
BETWEEN PUBLIC AND PRIVATE PAYERS  
Maeda JL1, Henke RM2, Marder WD2, Friedman BS3, Wong H4 
1Kaiser Permanente, Rockville, MD, USA, 2Truven Health Analytics, Cambridge, MA, USA, 
3Agency for Healthcare Research and Quality, Rockville, MD, USA, 4Agency for Healthcare 
Research and Quality (AHRQ), Rockville, MD, USA  
OBJECTIVES: The large variation in payments hospitals receive for similar 
services has captured the attention of payers and policy-makers looking for ways 
to curb excess health care spending. There is little empirical evidence regarding 
the specific role that patient, population, and market factors might have in 
driving price variation across small geographic areas and how these factors vary 
by payer. The purposes of this study are: (1) to provide insight into the 
relationship between patient, population, and market factors and payer-specific 
prices for several common conditions, and (2) to examine the factors that 
influence differences in the inpatient price per discharge between public 
(Medicare) and private payers among different hospital services. METHODS: We 
extracted hospital data from six states where a Healthcare Cost and Utilization 
Project (HCUP) price-to-charge ratio (PCR) was available from the 2006 State 
Inpatient Databases (SID). Even in states with PCR data, the PCR was not 
available for Kaiser Permanente hospitals so those discharges were excluded. 
The price per discharge was measured at the county-level for all discharges, an 
acute condition (acute myocardial infarction), and an elective condition (knee 
arthroplasty). Payer-specific inpatient prices were estimated by applying the 
HCUP PCR to total hospital charges. Ordinary least squares regression models 
were used to identify factors significantly associated with inpatient price per 
discharge by payer. RESULTS: Hospitals charged significantly higher prices to 
private payers compared to public payers. There was more variation in price per 
discharge for private payers compared to public payers for most hospital 
services. Specific market factors, including hospital competition, were associated 
with the price variation between payers. CONCLUSIONS: The larger variation in 
the price per discharge identified among private payers necessitates further 
exploration. It may stem from differences in negotiated prices and market power 
across small geographic areas, or the price restraints of public payers.  
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OBJECTIVES: To understand IVF policy landscape, reimbursement and access to 
treatment in the global health markets, and trends and drivers of change, for the 
purpose of identifying markets likely to support reproductive health franchises. 
METHODS: IVF ecosystems were assessed in 19 countries. We conducted a 
thorough review of published literature pertaining to Assisted Reproductive 
Technology (ART) policy, reviewed infertility organization and clinic websites 
and associated publications. Key market differences impacting the IVF 
environment were identified and analyzed for comparison. RESULTS: 
Opportunities in IVF must consider reimbursement policy, cultural influences, 
and med-tourism. While the US is one of the most advanced markets with 
respect to number of IVF cycles, technologies utilized, and cultural trends, 
healthplans provide no reimbursement and most patients pay 100% out-of-
pocket (OOP). Elsewhere, reimbursement varies greatly: Israel and European 
countries tend to provide more generous reimbursement than Latin America and 
Africa, however restrictions and requirements can greatly limit the coverage. 
Recent legislation changes in European markets have expanded reimbursement, 
and changes in South America are likely to evolve as reproductive health 
awareness and access to infertility treatment becomes more widespread. Finally, 
many patients do seek treatment abroad due to lower costs, shorter waitlists, 
and fewer restrictions: South America, South Africa, and Israel tend to be sought 
after destinations for patients willing to pay OOP. CONCLUSIONS: Reproductive 
health is unlike other therapeutic areas because reimbursement, alone, is 
insufficient to assess opportunity. Given the breadth of this poorly reimbursed 
therapeutic area, stakeholders must seek to appreciate the impact of cultural 
trends and med-tourism, including: declining birth rates, increasing access to 
IVF and reproductive health awareness, improvements in local economies and 
reforms to public policy. Manufacturers and policy makers should prepare to 
understand evolving market access and patient environments to effectively 
prioritize traditionally overlooked countries as key factors shift in the coming 
years.  
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OBJECTIVES: Quantify adoption patterns of quality improvement (QI) 
interventions designed to support evidence-based guidelines for hospital-
acquired pressure ulcer (HAPU) prevention. METHODS: We surveyed wound care 
nurses at 180 University HealthSystem Consortium (UHC) hospitals to determine 
which QI interventions were included in HAPU prevention protocols. The 
validated questionnaire organized 29 HAPU-specific QI interventions into four 
domains: Leadership; Staff; Information Technology (IT); and Performance & 
Improvement (P&I). Respondents checked QI interventions implemented 
anytime between 2007-2012. Descriptive statistics evaluated patterns of QI 
adoption and t-tests established statistically significant (p>0.05) increases in 
adoption. The points of time evaluated for QI adoption were 3rd-quarter, 2008 
when changes to Medicare policy discontinued HAPU reimbursement, and 2nd-
quarter, 2012. Increases were described in terms of scope (number of QI domains 
employed) and scale (number of QI interventions within domains). RESULTS: 
Fifty-five (30.6%) hospitals responded to the survey. Fifty-three (96%) hospitals 
implemented QI with HAPU prevention. Leadership interventions were most 
frequent, increasing in scope from 40-63% between 2008-2012; scale increased 
significantly for all leadership interventions, with “annual programs to promote 
pressure ulcer prevention” showing the greatest increase. Staff interventions 
increased in scope from 32-53%; signficant increases in scale occurred for six-of-
seven interventions, with “frequent consult driven huddles” undergoing the 
greatest increase. IT interventions increased in scope from 31-55%, and all five IT 
interventions increased significantly. Establishing an electronic HAPU 
trigger/alarm for high-risk patients accounted for the greatest adoption. P&I 
interventions increased in scope from 18-40%. Seven-of-nine P&I interventions 
had significant increases in scale, with “new skin care products…” increasing the 
most. CONCLUSIONS: UHC hospitals increased adoption of QI interventions, 
including scope and scale of QI strategies, since changes in Medicare policy to 
support HAPU prevention protocols and make use of novel technology and 
medical products. The next step in this research is to compare the effectiveness 
of different QI interventions.  
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OBJECTIVES: Due to emerging health care crisis of nationwide sharp decline in 
family physician (FP) supply, this study investigates the relationship between the 
supply of local FP workforce and the general population health status in the US 
federal regions. METHODS: A cross-sectional study was performed by merging 
the individual-level data from the 2009 Behavioral Risk Factor Surveillance 
System (BRFSS) with the county-level data from the 2011-2012 Area Resource File 
